Insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 06 03 2020
revised: 10 09 2020
accepted: 26 10 2020
pubmed: 7 11 2020
medline: 2 2 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

Cardiovascular disease (CVD) is prevalent in women after menopause, which may be associated with obesity, insulin resistance and metaflammation. Despite the recognized role of immunological mechanisms in vascular remodeling, the role of dendritic cells (DCs) is still unclear. The aim was to characterize monocyte-derived DCs (Mo-DC) in post-menopausal patients with type 2 diabetes (T2DM) and obese woman, without clinical manifestations of atherosclerosis. Obese post-menopausal women with or without T2DM were enrolled and were compared to age-matched healthy women. DCs obtained from patients were phenotypically and functionally characterized by flow cytometry and mixed lymphocyte reaction. MRNA integrins expression was assessed by real time RT-PCR; circulating fetuin-A and adiponectin levels were measured by ELISA. Phenotypic dysregulation of Mo-DC reported was related to a defective allogenic lymphocyte stimulation and to an increased mRNA of CD11c, CD18 and DC-SIGN/CD209 which regulate their adhesion to vascular wall cells. Fetuin-A and adiponectin levels were significantly altered and negatively correlated. Hyperglycaemia significantly impaired CD14 These data show a dysfunction of Mo-DCs obtained from precursors isolated from T2DM obese post-menopausal woman without any documented clinical CV event. Association of obesity to diabetes seems to worsen DC's phenotype and function and increase vascular inflammation.

Identifiants

pubmed: 33157116
pii: S0168-8227(20)30785-3
doi: 10.1016/j.diabres.2020.108528
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108528

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sara Paccosi (S)

Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.

Laura Pala (L)

Diabetology, Careggi University Hospital, Florence, Italy.

Barbara Cresci (B)

Diabetology, Careggi University Hospital, Florence, Italy.

Angela Silvano (A)

Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.

Marta Cecchi (M)

Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.

Roberto Caporale (R)

Cytofluorimetry and Immunotherapy Diagnostic Center, Careggi University Hospital, Florence, Italy.

Carlo Maria Rotella (C)

Department of Biomedical Clinical and Experimental Sciences, Endocrine Unit, University of Florence, Florence, Italy.

Astrid Parenti (A)

Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy. Electronic address: astrid.parenti@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH